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ABSTRACT
Probiotic Potential of Bacterial Isolates From ‘Amabere amaruranu’ Cultured Milk

by

Blaise Baalayel Boyiri

Probiotics are viable nonpathogenic microbes that positively affect host health.
Probiotics inhibit infection, activate immunity, and promote mucosal-barrier
development. Many microbes have probiotic activity. Nonetheless, the selection of
stable strains and their specific mechanism(s) of action are not fully elucidated. Bacteria
from ‘Amabere amaruranu’ cultured milk from Kenya were isolated and identified by
PCR sequence analysis of the 16S rRNA gene. Isolates were examined for stability to
acid and bile, antimicrobial activity, mucin production, and degradation and sensitivity to
antibiotics, hence their potential for probiotics. Lactobacillus isolates were acid unstable,
bile-stable, nonmucinolytic, and presented antibacterial activity. L. rhamnosus cell
fractions increased MUC4 and MUC3 expression in colon cells. Bacillus isolates were
acid and bile stable, nonmucinolytic and lacked antimicrobial activity. In conclusion,
Lactobacillus isolates that were nonmucinolytic, stable in bile, demonstrated
antibacterial activity, sensitive to antibiotics, and stimulated increase MUC4 and MUC3
levels in colon cells could be potential probiotics.
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CHAPTER 1
INTRODUCTION AND LITERATURE REVIEW

Definition and History of Probiotics
The concept of ingesting live microbes for their potential health benefits evolved
around the early 20th century (Metchnikoff, 1907). This idea came from observations
that were made by Ilya Ilyich Metchnikoff (1845-1916) that the longevity of native
Bulgarians could be attributable to their consumption of cultured dairy products (Bibel,
1988). Bacterial cultures have long been used in dairy products to develop a distinctive
flavor and increase shelf life (Bruhn et al., 2002). The practice of adding selected viable
microbes to food is now referred to as ‘probiotics’ (O’Sullivan, 2001). Probiotics are
viable nonpathogenic microbes that have the potential to confer health benefits on their
host when ingested in sufficient amounts (FAO/WHO Joint Working Group, 2002; Fuller,
1991; Shanahan, 2005). Interestingly, both live and dead probiotic cells are efficacious
in function, and their cell components can effectively act as biological response
modifiers (Adams, 2010). Probiotic activities are not limited to only the gastrointestinal
tract but seem to demonstrate significant biological effects on distant organs and tissues
as recently reviewed by Adams (2010). A wide variety of bacterial species could
provide probiotic activity, but the most common strains in commercial use are the
lactobacilli and bifidobacteria groups (Reid, Anukam, & Koyama, 2008; Shah, 2007).
Lactic acid bacteria in particular have been consumed safely by all human generations
in various fermented dairy foods (Fuller, 1992; van der Kamp, 1996). Fuller (1987)
reported an increase interest in the use of live microbial agents for health maintenance
12

and disease prevention. This report was supported by Brady, Gallaher, and Busta
(2000) and Isolauri (2000) that several scientific and medical communities have
developed interest in exploring the functionality and application of probiotics in human
health.

Sources of Probiotic Bacteria
Collins, Thornton, and Sullivan (1998) pointed out the imperativeness to always
establish the source of probiotic bacteria in order to substantiate their health claims.
Bacterial strains among human gut commensal microbiota and milk microflora that
demonstrate substantial stability and beneficial properties are potential sources of
probiotics (Isolauri, Kirjaviainen, & Salminen, 2002a). Many microorganisms including
lactobacilli, bifidobacteria, streptococci, and Saccharomyces are commonly considered
for probiotic preparations (Goldin & Gorbach, 1992).

Cultured-milk as Source of Probiotic Strains
The high nutritional value and water content of milk makes it one of the foods that
harbor complex microbial communities (Quigley et al., 2011). The understanding of the
microbial communities in milk and other dairy products is important. The microbes
determine the quality of the milk products. These microbes may include spoilage
bacteria or potential pathogens as well as beneficial micro-organisms (Cousin, 1982).
The diversity of microbial communities of raw milk for instance may be influenced by the
location of the animal and the season of milking it (Bonizzi, Boffoni, Feligini, & Enne,
2009; Randazzo, Pitino, Ribbera, & Caggia, 2010). Other factors that affect the
13

microbial composition include handling and the storage procedures. Most commonly
studied microbial communities in milk are the culturable microbes. These include the
Lactobacillus, Streptococcus, Enterococcus, Lactococcus, Leuconostoc, Weisella, and
Pediocococus strains. Strains of other genera such as Staphylococcus,
Propionibacterium, Corynebacterium, and Brevibacterium as well as Saccharomyces
may also be present (Coppola, Blaiotta, & Ercolini, 2008). It is however apparent that
the culture-based method of studying the microbial composition of milk does not usually
account for all strains. This is because the method relies on isolation and cultivation of
the strains for identification and as a result may fail to isolate some species that are
represented in low numbers. Hugenholtz, Goebel, and Pace (1998) reported that
minority species may be out-competed in laboratory media by numerically more
abundant microbial species.

Selection Criteria for Probiotics
The selection of probiotic strains has been in large part based on historical
recognition of safe consumption of cultures. It is essentially based on reports of many
years of consuming a particular culture without obvious harmful side effects (KoppHoolihan, 2001). Most probiotic strains are similar to the natural gut commensal
microflora. Preferable probiotics strains are those of human origin (Collins et al., 1998).
The definition of probiotics requires adequate verification of the efficacy and safety of
selected strains, thus, assessment of these factors constitutes an important part of the
characterization of probiotics for human use (Isolauri, Salminen, & Ouwehand, 2004).
Among the prerequisites for selecting probiotic bacteria is their ability to show high
14

capacity to adhere to and colonize the gut (Huis in’t Veld, Havenaar, & Marteau, 1994).
Additional considerations for selecting suitable probiotics are that the strains should not
have the capacity to degrade mucins. This is to avoid possible degradation of the
protective mucus layer of the digestive tract (Zhou, Gospal, & Gill, 2001). Furthermore,
suitable probiotic strains should be nonpathogenic even in immunocompromised hosts
(Collins et al., 1998) and should demonstrate appreciable ability to exert beneficial
effects on their host (Kopp-Hoolihan, 2001). The selected strains should show stability
to stress, especially that of digestive tract conditions including tolerance to low pH and
high concentration of bile acids. This establishes the ability of the strain to survive and
proliferate in the in vivo conditions of the digestive tract (Collins et al., 1998). Saarela,
Alakomi, Puhakka, and Matto (2009) reported that the probiotic isolates usually
encounter various stressful conditions during isolation, formulation into food or
supplements, storage, and transit along the gastrointestinal tract. Some of the common
stress conditions as noted by Antione (2011) included refrigeration storage at 4 oC,
transit along mouth and gastrointestinal tract temperatures of about 25 oC and 37 oC
respectively, chemical challenges including hyper-acidic gastric environment of about
pH1 to 2, and neutralization or detergent effects of bile in the small intestines. However,
Saarela et al. (2005) reported that tolerance of cells to stress is strain specific and that
cells at stationary phase of growth seemed to be more tolerant to stressful conditions
than actively growing cultures (Saarela et al., 2009). Furthermore, desirable probiotic
strains should not provoke the host immune responses against themselves or their
products (Pouwels, Leer, & Posno, 1992). Probiotic strains are also required to
demonstrate appropriate antibiogram profiles including sensitivity to antibiotics and
15

resistance to metronidazole and that to some extend prevents the used of strains that
may transfer antibiotic resistance trait to other gastrointestinal tract dwellers. They are
also required to possess effective immunostimulatory effects on the mucosal immune
system especially in the activation of cytokines (Collins et al., 1998).

Probiotics in Food Synthesis
Microorganisms have been involved in the preparation of cultured foods by many
communities around the world. These organisms have demonstrated appreciable
potential to improve the quantity, availability, and digestibility of some dietary nutrients
(Kopp-Hooligan, 2001). There are reports of increase concentration of folic acid in
yogurt and ‘bifidus milk’ (commercial milk preparation that contains Bifidobacterium
bifium) through fermentation with lactic acid bacteria (Alm, 1982). Fermentation of food
with lactic acid bacteria also increases the content of vitamin B complexes and
promotes the production of short-chain fatty acids and the hydrolysis of amino acids
(Friend & Shanahan, 1984).

Therapeutic Effects of Probiotics
A growing body of scientific evidence supporting probiotic contributions to human
health is available. Modification of gut microbial communities by probiotic therapy has
demonstrated therapeutic potentials in clinical conditions associated with barrier
dysfunction and inflamed mucosa (Isolauri, 2001). Probiotics aid digestion, inhibit
pathogenic infections, promote development of intestinal integrity, reduce pH of the
large bowel, activate mucosal immunity, and suppress tumorigenesis and cancer.
16

Probiotics in Aiding digestion and Improving Bowel Movement
Lactose intolerance is a common complaint for some people when they consume
milk or dairy products. It involves the difficulty for people with this condition to digest the
lactose component in milk. There are several reports about the ability of some cultures
to provide a remedy to this condition through the production of lactase for the hydrolysis
of lactose during fermentation and digestion (Savaiano & Levitt, 1987). Probiotics also
contribute to improvement of bowel movement especially among the elderly. Significant
laxative effect from the consumption of Bifidobacterium cultured milk was reviewed by
Yaeshima (1996).

Probiotics in Mucosal Barrier Development and Reduction of Inflammation
The mucosal barrier consists of a single cell layer epithelium and an aggregate of
other secretory cells and gut immune cells and their products. The epithelial cell layer of
the gastrointestinal tract is strategically located between the many microbes and
antigens of the intestinal lumen and the inflammatory and immune effector cells of the
lamina propria (Mack, Michail, Wei, McDougall, & Hollingsworth, 1999). It is capable of
regulating the production of selected chemokines in response to invasive bacteria
(Yang, Eckmann, Panja, & Kagnoff, 1997) and as a result may be an important
component in the development of the host innate and adaptive immune responses. The
interaction of the gut epithelium with resident microbiota also contributes to the
development and the function of the mucosal barrier. Isolauri (2001) illustrated the
importance of gut microflora in the intestinal defense barrier. She demonstrated in the
study that the absence of intestinal microflora resulted in an increase in antigen
17

transport that led to increased inflammation. Inflammation is mediated by the increased
production of proinflammatory tumor necrosis factor (TNF) that contributes to the
recruitment and activation of immune cells, the release of cytolytic enzymes and
reactive oxygen species (ROS), and the consequent exacerbation of tissue damage at
sites of inflammation (Ganesan, Travis, Ahmad, & Jazrawi, 2002; Van Deventer, 1997).
This is demonstrated in the rise in levels of proinflammatory cytokines including TNF at
the local sites of inflammation and in the peripheral circulation of patients with Crohn’s
Disease (Borruel et al., 2002; Grip, Janciauskiene, & Lindgren, 2004; MacDermott,
Sanderson & Reinecker, 1998; Present et al., 1999). Emerging clinical evidence is
reported about the specific beneficial impacts of probiotics in the development of the
mucosal barrier and the possible prevention and/or treatment of gastrointestinal
inflammatory diseases. The anti-inflammatory action of Lactobacillus reuteri has been
demonstrated in previous studies with findings supporting its ability to inhibit
experimental colitis in transgenic interleukin-10- deficient mice (Madsen, Doyle, Jewell,
Tavernini, & Fedorak, 1999). Furthermore, Pena et al. (2004) reported the ability of L.
reuteri to reduce the levels of proinflammatory cytokines including TNF-alpha in mice
with colitis. Probiotics involvement in managing the condition of necrotizing enterocolitis
has been reported by Bin-Nun et al. (2005), Hoyos (1999), Lin et al. (2008), and
Ruemmele et al. (2000). In premature infants, for instance, probiotics are thought to
transiently improve the balance of colonizing bacteria that facilitate the development of
mucosal immunity to prevent excessive inflammation associated with necrotising
enterocolitis (NEC) (Nanthakumar, Fusunyan, Sanderson, & Walker, 2000). Khailova et
al. (2009) recently provided evidence for the protection against NEC in neonatal rat
18

model through oral administration of Bifidobacterium bifidum and suggested that the
protection was associated with reduction of ileal inflammation, regulation of mucus layer
formation, and improvement of intestinal integrity.

Role of Probiotics in Production of Mucins and the Importance of Mucins
One important structural component that protects the mucosal surface is the
mucus layer overlying the mucosal membrane. The mucus layer is a result of the
interaction of various mucosal secretions including water, mucin glycoproteins, trefoil
peptides, surfactant phosphates, electrolytes, and antibodies (Macfarlane,
Woodmansey, & Marfarlane, 2005). Large carbohydrate-rich mucin glycoproteins form
the predominant constituents of mucus (Aksoy, Thornton, Corfield, & Sheehan, 1999).
The mucins are synthesized, stored, and secreted from cells on the epithelial surface of
ducts and lumens and from enterocytes and goblet cells in the underlying mucosa
(Aksoy, Corfield, & Sheehan, 2000). Mucins are particularly secreted in the respiratory,
gastrointestinal, and genital tracts and in other accessory organs such as the pancreatic
glands and gallbladder (Reid & Harris, 1998). The mucus layer provides residence and
source of nutrients to the gut microflora (Derrien, Vaughan, Plugge, & Vos, 2004). It
however limits the access of these microbes in the lumen from direct interaction with the
epithelium through simple steric hindrance (Dai, Nanthkumar, Newberg, & Walker,
2000). These barriers inhibit epithelial cell adherence and, thus, interrupt colonization
and possible invasion of pathogens. Mucus also provides hydrophobic properties to the
mucosal surface and therefore prevents the delivery and influx of water soluble bacterial
product and toxins (Lugea, Salas, Casalot, Gaurner, & Malagelada, 2000; Mack, Ahrne,
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Hyde, Wei, & Hollingsworth, 2003). Furthermore, the mucus layer lubricates and
physically protects the mucosa against dehydration and mechanical injuries
(Lichtenberger, 2000; Matsuo, Ota, Akamatsu, Sugiyama, & Katsuyama, 1997).
Transmembrane mucins remain anchored to the epithelial cell membranes. They
perform functions including trophic, signaling, and adhesive roles in various epithelial
cell processes (Andrianifahanana, Moniaux, & Batra, 2006). Moniaux, Escande,
Porchet, Aubert, and Batra (2001) previously reported some major roles of mucins in
growth, improvement of epithelial integrity, suppression of carcinogenesis and
metastasis, as well as in the promotion of fetal development. There are several reports
in favor of probiotics involvement in the production of various types of mucins and the
specific contributions of each mucin to gastrointestinal health. Fyderek et al. (2009)
reported that mucus constituted an integral part of the mucosal barrier and plays
important roles in hindering the penetration of the mucosa by luminal bacteria. It also
prevents the interaction between bacterial products and host cell receptors, thus
preventing the tendency to trigger inflammatory processes. This was supported by
McAuley et al. (2007) earlier report that surface mucins play the role of targets to
invading pathogens by limiting the interaction of the pathogens with the gut epithelium.
It also supported the suggestion of Gork et al. (1999) that secretory mucin glycoproteins
in the gut seemed to reduce the possibility of bacterial attachment. These findings
further supported a previous study by Pullan et al. (1994) in which they suggested that
reduction in the mucus layer thickness among adult inflammatory bowel disease (IBD)
patients caused an increased exposure of microbes to the gut immune system that led
to sustained inflammation. Mack et al. (1999) reported the role of a specific
20

Lactobacillus plantarum (strain 299v) to enhance the production and secretion of
mucins (MUC2 and MUC3) from human intestinal (HT-29) epithelial cells. Follow-up
studies on the role of secreted mucin-3 (MUC3A and MUC3B) by Mack et al. (2003)
provided evidence to the effect that MUC3 seemed to inhibit the attachment of
enteropathogenic Escherichia coli to the epithelium of the gastrointestinal tract. Similar
effect of probiotic mixtures in increasing muc2 gene expression and muc2 glycoprotein
secretion in rat colon was reported by Caballero-Franco, Keller, De Simone, and
Chadee (2007). Therefore, during selection of probiotic strains, it is important to test and
confirm that the strain does not degrade mucins. This is to avoid possible disruption of
the protective mucus layer by the strains after ingestion (Fernandez, Boris, & Barbes,
2005; Zhou et al., 2001). However, the ability of potential probiotic strains to stimulate
the production of mucin glycoproteins production in the gut epithelium is considered as
a positive trait.

Probiotics in Improving Gut Microflora and Intestinal Health
The gastrointestinal tract of a newborn infant is devoid of the resident gut
microbiota and the colonization of premature infant’s gut with the characteristic
microflora generally takes longer to establish. As a result of the slow colonization
process, premature infants at this stage are susceptible to intestinal infections including
ulceronecrotic colitis (Pinegin, Korzhunov, Ivanova, Volodin, & Goncharova, 1983). A
rapid establishment of representative intestinal microflora in premature infants was
demonstrated by Akiyama et al. (1994) through the administration of a Bifidobacterium
breve strain.
21

Probiotics in Inhibition of Infections
Although the human gastrointestinal tract is sterile at birth, it is rapidly colonized
by a dynamic mixture of microbes soon after birth (Tappenden & Deutsch, 2007). The
colonization of the gut that begins promptly after birth is affected by the mode of
delivery, early feeding strategies, and the hygiene and related conditions around the
child (http://chp.sagepub.com/content). Hence the lumen ultimately presents a major
entry route to many food and water borne infections as a result of the constant exposure
of the gut epithelium to gastrointestinal content (Hansson, 2012). Despite this enormous
challenge the gut is hardly overwhelmed by pathogenic infections due to the presence
of effective microbial barriers (Kim & Khan, 2013). Several approaches by which the
resident microbiota and probiotics impede pathogenic infection have been proposed.
Lewus, Kaiser, & Montville (1991) reported the ability of lactic acid bacteria to directly
inhibit the growth of pathogens through production of bacteriocins. In vitro studies
suggested that probiotics potentially act favorably in the host through modification of the
resident microbial flora to promote effective competition against pathogens for adhesion
to the intestinal epithelium or compete against pathogens for necessary nutrients and
growth factors. Others produce antitoxin effects and reverse some of the consequences
of infection on the epithelium, such as secretory changes and neutrophil migration
(Michail & Abernathy, 2002, 2003). Probiotics are also thought to inhibit infections
through reduction of the local gut pH by stimulating the activities of lactic acid producing
microflora (Langhendries et al., 1995). Lactobacillus derived probiotics for instance may
influence the reduction of the pH of the microenvironment of the gut to the detriment of
pathogenic microbes (Fayol-Messaoudi et al., 2005). Lactobacillus rhamnosus GG in
22

particular secretes an antimicrobial substance distinct from lactic acid that has inhibitory
activity against other bacteria in the pH range of 3 to 5 (Silva, Jacobus, & Gorbach,
1987). This is demonstrated in the impaired growth of virulent microbes in a pHdependent manner in coculture experiment with Lactobacillus species (FayolMessaoudi et al., 2005). Talarico and Dobrogosz (1999) reported that Lactobacillus
reuteri residing in the gut inhibited a wide spectrum of microorganisms with the
antibacterial compound reuterin. There are preliminary evidence that probiotic bacteria
may inhibit the gastric colonization and activity of Helicobacter pylori, which is
associated with gastritis, peptic ulcers, and gastric cancers (Kopp-Hoolihan, 2001).
Aiba, Suzuki, Kabir, Takagi, and Koga (1998) and Kabir et al. (1997) reported the ability
of Lactobacillus salivarius to inhibit Helicobacter pylori colonization in in vitro studies as
well as in mice. Probiotic secretions have the potential to inhibit growth and attenuate
virulence of some enteric bacterial pathogens (Sherman, Ossa, & Johnson-Henry,
2009).

Probiotics in the Prevention of Diarrhea in Infants and Adults
Diarrheal conditions are caused by pathogenic bacterial and viral overgrowth in
either the small intestines or colon. Regardless of the mechanisms leading to the
diarrheal condition, the end result is always accumulation and expulsion of fluids and
electrolytes (Bezkorovainy, 2001). The most extensively studied gastrointestinal
condition treatable by the administration of probiotics is acute infantile diarrhea (Isolauri
et al., 2002a). In patients hospitalized for acute rotavirus diarrhea, Lactobacillus strain
GG (ATCC 53103) as fermented milk or as freeze-dried powder significantly reduced
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the duration of the diarrhea compared to a placebo group given pasteurized yogurt
(Isolauri et al., 1991). This was supported by Saxelin’s (1997) report that Lactobacillus
rhamnosus GG mediated the prevention of Escherichia coli enterotoxin traveler’s
diarrhea.

Probiotics in the Treatment of Antibiotic-associated Diarrhea
Antibiotics are microbial metabolites that can inhibit the growth of other
microorganisms. Antibiotic-associated gastrointestinal disorders are well recognized
and Lactobacillus rhamnosus GG has demonstrated effective prophylactic effect against
antibiotic-associated diarrhea (Akiyama et al., 1994). Black, Einarsson, Lidbeck,
Orrhage, and Nord (1991) reported the reduction in incidence and recolonization time of
ampicillin-associated diarrhea through the delivery of Bifidobacterium longum and
Lactobacillus acidophilus probiotic mixture. Similar effect for erythromycin-associated
diarrhea through the administration of yogurt containing Bifidobacterium longum has
also been reported by Colombel, Cortot, Neut, and Romond (1991).

Probiotics in the Activation of Mucosal Immunity
The gut associated lymphoid tissue makes the gastrointestinal tract the largest
lymphoid or immune organ in the human body (Targan & Shanahan, 1994). Animal
models and human studies have found that probiotic bacteria are able to enhance
nonspecific and specific immune responses by activating macrophages, increasing
levels of cytokines, elevating natural killer activity, and increasing levels of
immunoglobulins (Sanders, 1999). Mallin, Suomalainen, Saaxelin, and Isolauri (1996)
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reported increase in secretory IgA levels through the ingestion of certain strains of
Lactobacillus. This report agreed with the findings by Arunachalam, Gill, and Chandra
(2000) in which a doubled-blind, placebo-controlled study of 12 human subjects were
found to have increased immunity due to ingestion of Bifidobacterium lactis strains.

Probiotics in Autoimmune Disorders and Allergies
Information provided by Cabana, McKean, Wong, Chao, and Caughey (2007)
highlighted the importance of infant exposure to environmental microbes for appropriate
development of the immune system. This emphasizes the new version of the “hygiene
hypothesis” that proposes reduced exposure to environmental and/or enteric stimuli,
including microbes, underlies the rising incidence of childhood atopic and autoimmune
diseases (http://chp.sagepub.com/content). Preliminary studies are pointing to the
potential for probiotics to modulate allergic reactions through improvement of the
mucosal barrier function (Naidu, Bidlack, & Clemens, 1999). The rationale in probiotics
capacity to alleviate allergy by modulating the intestinal microbiota is supported by
observations in which allergic children were found to have demonstrated a different
microbiota composition than healthy infants. Kalliomaki et al. (2001) reported that the
main changes associated with the allergic trait were less frequent colonization with
lactobacilli and lower counts of bifidobacteria.
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Efficacy and Safety of Probiotic Therapy
Although it has been proposed that inactivated microbes and probiotic cell
components can significantly act as biological response modifiers on various processes
in tissues and organs (Adams, 2010; Isolauri et al., 2002b; Zhang, Nan, Ricardo, & Neu,
2005), probiotics are generally reported to elicit their beneficial effects when the strains
were ingested alive and in sufficient quantities (FAO/WHO Joint Working Group, 2002).
The maintenance of probiotic shelf life has always been an issue of concern during
preparation of probiotic foods and supplements. Moreover, considerable differences
exist in the bioavailability, biological activities, doses, and microfloral composition
among probiotic preparations (http://journals.lww.com/jpgn 2006). These disparities
raise the question of reliability in taking probiotics for their therapeutic effects. In
addition to concerns regarding the efficacy of probiotics is also the issue of safety
(Champagne, Roy & Roy, 2005; Philips, Kaliasapathy, & Tran, 2006; Vinderola,
Prosello, Ghiberto, & Reinheimer, 2000). Snydman (2008) stated three theoretical
safety concerns in taking probiotics, including the danger of probiotic sepsis, metabolic
effect on the gastrointestinal tract, and possible horizontal transfer of antibiotic
resistance to potential pathogenic gastrointestinal dwellers. Regardless of the several
promising findings on the safety of probiotics from studies involving immunecompromised patients with HIV (Apostolou et al., 2001) and transplant populations
(Rayes et al., 2005), the concerns regarding probiotic safety are still not entirely
addressed. There are several reports of bacteremia and fungemia with lactobacilli and
saccharomyces organisms, especially in patients with immunocompromised status or
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indwelling central venous catheters (Enache-Angoulvant & Hennequin, 2005; Land et
al., 2005). These concerns raised the necessity for broader investigation into not only
the beneficial effects of probiotics but also the safety of the products in human health
(Abe, 2010).
Motivation and Scope of Current Study
Several new findings keep trickling in about novel probiotic strains and their role in
various aspects of human health. So far many different bacterial and fungal strains with
probiotic activities have been reported. Nonetheless, the identification and selection of
probiotic strains, their specific effects, mechanism(s) of actions, and efficacious dosage
are not fully elucidated yet. Motivated by the diverse potential sources of novel probiotic
strains and the interesting emerging benefits of several strains, I seek to investigate the
following questions:
1. Are bacterial isolates from ‘Amabere amaruranu’ cultured-milk, a traditional
cultured-milk preparation of the Kisii people of Southwest Kenya, stable to
digestive tract conditions?
2. Do the cultured milk isolates show sensitivity to antibiotics?
3. Do the bacterial isolates show capacity to degrade mucin?
4. Do the bacterial isolates have the potential to stimulate mucin glycoproteins
(MUC3 and MUC4) production in human enterocytes?
Hypothesis
Because no deleterious effects from the consumption of ‘Amabere amaruranu’
cultured-milk (a traditional cultured-milk preparation by the Kisii people of Southwest
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Kenya) has been reported, the bacterial isolates in the preparation could be stable to
digestive tract conditions and could have probiotic benefits.

Objectives
1. To isolate, identify, and determine the stability of cultured-milk bacterial
isolates to digestive tract conditions.
2. To examine the isolates for antimicrobial activity, sensitivity to antibiotics, and
mucin degradation activity.
3. To examine the isolates for their effect on human normal colon cells regarding
the production of mucin glycoproteins (MUC3 and MUC4).
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CHAPTER 2
MATERIALS AND METHODS
Experimental Materials
‘Amabere amaruranu’ Cultured-milk
The cultured milk was obtained from a native of Kenya in Johnson City, Tennessee.
The pH of the milk was measured and isolation of bacteria from it begun immediately
after it was received.

Acid Buffer
The pH of 1X Phosphate buffered saline pH7.4 (Gibco Invitrogen, Grand Island, NY
14072) was adjusted with drops of 1M HCl to pH2.0 with the aid of Ultra Basic –10
pH/mV meter (Denver Instrument, Thermo Scientific, Cat number 02-2283).

Culture Media for Milk Isolates
MRS Media: This medium so-named after its inventors; de Man, Rogosa and
Sharpe; is an enriched medium that was developed in 1960 for the growth of
Lactobacillus species. MRS agar plates were prepared by suspending 31 g of Thermo
Scientific Oxoid MRS agar (Cat. number CM0361B) in 500mL of dH 2 O in a sterile 1000
Pyrex bottle. The suspension was autoclaved for 20 minutes at 121 ᵒC. The medium
was then put in 55 ᵒC water bath to cool before pouring it into sterile Petri dishes. The
dishes were covered immediately to avoid contamination and allowed to solidify at room
temperature. The plates were then stored at 4 ᵒC for later use. The MRS broth was
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prepared by suspending 26 g of Thermo Scientific Oxoid MRS broth (Cat. number
CM0359B) in 500 mL of dH 2 O in a sterile 1000 mL Pyrex bottle and autoclaving it for 20
minutes at 121 ᵒC. The broth was cooled and stored at room temperature for later use.
M17 media: This medium is an enriched medium for isolation and study of bacteria
from milk in the laboratory. It was developed in 1975 by Terzaghi, and Sardine. The
M17 broth was prepared by suspending 18.63 g of Thermo Scientific Oxoid M17 broth
(Cat. number CM0817B) in 500 mL of dH 2 O in a sterile 1000 mL Pyrex bottle and
autoclaving it for 20 minutes at 121 ᵒC. It was cooled and stored at room temperature
for later use.
M17 agar plates were made by suspending 18.63 g of Thermo Scientific Oxoid M17
broth (Cat. number CM0817B) and 7.5 g of Bacto agar in 500 mL of dH 2 O in a 1000 mL
Pyrex bottle and autoclaving it for 20 minutes at 121 ᵒC. The medium was then put in 55
ᵒC water bath to cool before pouring it into sterile Petri dishes. The dishes were covered
immediately to avoid contamination and allowed to solidify at room temperature. The
plates were then stored at 4 ᵒC for later use.

Bovine Bile Conditioned Medium
Three percent bovine bile (Sigma Aldrich Co. 3060 Spruce Street, St. Louis, MO
63103 USA, Cat. number B-3883) was prepared by dissolving 1.5 g of dried bovine bile
in 50 mL of 1X Phosphate buffered Saline pH7.4 (Gibco Invitrogen, Grand Island,
NY14072). The suspension was filter sterilized using PVDF membrane; Millipore Millex
– GV 0.22µm pore size (Fisher scientific, Cat. number SLGVR04NK). 0.5mL of the 3%
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bovine bile solution was then added to 4.5 mL of M17 and MRS sterile broth to prepare
0.3% bovine bile conditioned media.

Mucinized Agarose Medium B
Point-five percent mucinized agarose medium B was prepared with partially purified
porcine gastric mucin type III (Sigma Aldrich Co. 3060 Spruce Street, St. Louis, MO
63103 USA, Cat. number M1778) by dissolving 0.5% (w/v) mucin into 1.5 % (w/v)
medium B (with composition 7.5 g Trypton, 7.5 g Casitone, 3.0 g Yeast extract, 5.0 g
Meat extract, 5.0 g NaCl, 3.0 g KH 2 PO 4 .H 2 O, 0.5 g KH 2 PO 4 , 0.5 g MgSO 4 .7H 2 O, 0.5 g
Cysteine HCl, 0.02 g Rasarurin, 5 g mucin, 15 g agarose ) with or without 0.3% D-(+)glucose).

Human Colon CCD 841 CoN Cell Line
Human colon CCD 841 CoN cell line was obtained from American Typed Culture
Collections® (Cat. number CRL-1790). Cells were cultured in Dulbecoco’s modified
Eagle’s medium (DMEM) containing 10% fetal calf serum (FCS) and 5% Penicillinstreptomycin (Corning cellgro®, Mediatech, Inc, Manassas, VA 20109) until the cells
reached 70% confluence. The cells were passaged two times and stored in aliquots in
complete DMEM storage media in liquid nitrogen.

Cultured-milk Bacterial Extracts
Lactobacillus rhamnosus isolated and identified from ‘Amabere amaruranu’ cultured
milk was cultured in MRS broth in a 250 mL flask with sterile gauze stopper. The flask
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was incubated at 37 ᵒC on shaker in aerobic condition until the culture reached
stationary phase of growth (OD 600 nm of 1.0). One milliliter of culture broth was
transferred into a clean microfuge tube and centrifuged at 8000 rpm for 5 minutes at 4
ᵒC. The cell pellets were washed with sterile PBS 1X pH7.4 and resuspended in 1mL
PBS 1X pH7.4. The suspension was then sonicated on ice using a sonicator (Fisher
Scientific Co., Toronto, ON, Canada) at 40% amplitude for 18 seconds followed by 2
minutes intervals of rest and repeated 5 times to avoid heating and denaturation of
proteins. The suspension of sonicated cells was then centrifuged at 125 x g for 5
minutes and the collected supernatant was filter-sterilized using PVDF membrane;
Millipore Millex – GV 0.22 µm pore size (Fisher scientific, Cat. number SLGVR04NK)
and used as the sample for L. rhamnosus cytoplasmic fractions (BCF) for the testing
effect of bacterial extracts for MUC4 and MUC3 production in normal colon cells. The
bacterial cell extracts were stored at -20 ᵒC and used in testing with the CCD 841 CoN
cells at 70% confluence for effect in mucins production.

Experimental Methods
Preparation of ‘Amabere amaruranu’ Cultured-milk
Cultured-milk preparations are widely eaten in many communities in Kenya and
other parts of the world. A sample of cultured-milk from the Kisii region in Southwest
Kenya (Figure 1), (Nationsonline.org, 2014) is the source of the bacterial isolates in this
study. The milk sample is called ‘Amabere amaruranu’ (Figure 2). Fresh milk is usually
pasteurized and poured into clean gourds (Figure 2), containing a stock culture of
‘Amabere amaruranu’ cultured milk usually once in about 24-48 hours. The source of
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the original stock culture is not known. It is believed to constitute part of the rich heritage
of the Kisii people that has been handed down from many generations and it is
preserved in the community through continuous use by households. Because the milk is
prepared this way, it of necessity contains bacteria. The composition of the bacteria in
this preparation has not been reported, but the bacterial isolates could be potentially
beneficial because no harmful effect from its consumption has ever been reported.
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Figure 1. Map of Kenya showing Kisii Region in the Southwest of Kenya.
nationsonline.org. (2014) Political Map of Kenya. One World - Nations Online (OWNO).
Accessed May 2014: www.nationsonline.org/oneworld/map/kenya_map2.htm
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Figure 2. Sample of ‘Amabere amaruranu’ Cultured-milk and Gourd

Isolation of Bacteria from ‘Amabere amaruranu’ Cultured-milk
One millimeter of a sample of ‘Amabere amaruranu’ cultured milk preparation was
first homogenized with 9 mL of 1X sterile phosphate buffer saline (PBS) at pH 7.4. The
homogenate was serially diluted by 10-fold using 1X sterile PBS at pH 7.4. Then 0.25
mL aliquots of the final dilution were inoculated on MRS agar at pH 6.2 (Thermo Fisher
Scientific, Pittsburgh 15275, Cat number CM0361B; De Man, Rogosa, and Sharpe,
1960) and M17 agar at pH 6.2 (Thermo Fisher Scientific, Pittsburgh 15275, Cat number
CM0785B; Terzaghi and Sandine, 1975). A set of the plates were incubated in
anaerobic conditions (using a standard anaerobic jar chamber (Thermo Fisher scientific,
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cat number B-260671) with the anaerobe container system sachet (Fisher scientific, cat
number B-260678). A second set of plates was incubated in aerobic condition.
However, both sets of plates were incubated at 37 ᵒC for 48 h. Individual colonies on
the M17, and MRS agar plates were randomly picked from representatives of all
morphologically distinct colonies for five other successive subcultures on fresh plates to
purify the colonies (Leisner et al., 1997). Samples of each pure isolate were stored at 80ᵒC in a microbankTM bacterial and fungal preservation system (Pro-Lab Diagnostic, 20
Mural St., Unit 4, Richmond Hill, OH; Fisher Scientific, Cat number 22286-154). Working
cultures were kept on MRS or M17 agar slants at 4 ᵒC and streaked every 4 weeks on
agar plates (Herrero, Gonzalez, & Suarez, 1996; Samelis, Maurogenakis, &
Metaxopoulos, 1994).

Selection of Bacterial Isolates by Colony Morphology
Colonies of bacterial isolates were selected on agar plates based on distinction in
colony morphology. Colonies with distinction in morphology including pigmentation,
elevation, margin features, and size were randomly selected and further streaked for
purification. The colonies were then gram stained and the slides were examined by
microscopy using a compound light microscope.

Identification of Cultured-milk Isolates by PCR
Cultured-milk isolates were identified by amplifying and comparing the 16S rRNA
gene with that of known bacteria as described by Ralitsa, Sheuerman, Chakraborty, and
Lampson (2012). The 16S rRNA gene is a preferred target of identification because it
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possesses both highly conserved and highly variable domains. The conserved regions
provide the site for amplification of the gene with universal PCR primers, while the
hypervariable region facilitates the identification of the corresponding micro-organisms
(Delbes & Montel, 2005). Bacterial isolates that were identified as pure were grown on
MRS or M17 agar plates for 24 hours, after which, for each isolate, a single isolated
colony was picked from the plate and suspended in a 1.5 mL Eppendorf tube containing
1µL of dH 2 O. The cells were dispersed by forcefully spinning the loop against the
bottom of the tube to produce a homogeneous suspension. This suspension was used
as a DNA template to perform polymerase chain reaction (PCR). This reaction is used
to isolate and amplify the 16S rRNA gene from bacterial cells. The sequence of this
gene is commonly used to identify unknown bacterial genera. The following PCR
reagents were mixed with the bacterial samples to undergo DNA amplification: dH 2 O 22
µL, 10x PCR Buffer (Go Taq Flexi, Promega) 10 µL, Dimethyl sulfoxide (Corning
cellgro) 5 µL, 25 mM MgCl 2 (Promega) 3 µL, 10 mM Deoxyribonucleotide Triphosphate
Mix (Promega) 1 µL, 20 µM Forward Primer (63f) 1.25 µL, 20 µM Reverse Primer
(1387) 1.25 µL, single bacterial colony (DNA) template 1 µL and Taq Polymerase (Go
Taq Flexi, Promega) 0.5 µL.
The sequence of the forward primer, 63f, used in this reaction is 5’-CAG GCC
TAA CAC ATG CAA GTC-3’ and the sequence of the reverse primer, 1387r, used is 5’GGG CGG WGT GTA CAA GGC-3’ where ‘W’ is a code for A or T
(http://www.basic.northwest.edu/biotools/oligocalc.html). Fifty microliters of this mixture
of reagents was transferred into a 250 µL microfuge tube for each bacterial isolate and
placed in a thermocycler in which they were exposed to the following cyclic temperature
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changes: 95 ᵒC for 3 minutes, 95 ᵒC for 1 minute (repeated for 29 cycles), 55 ᵒC for 1
minute, 72 ᵒC for 2 minutes (repeated for 29 cycles), 72 ᵒC for 5 minutes, and hold at 4
ᵒC. The samples were then checked after completion of the thermocycle program on a
0.75% agarose gel to determine if DNA was successfully amplified by using gel
electrophoresis. The amplified DNA was then purified using GeneClean Turbo kit. The
purified samples were sent to the DNA Sequence Service at the University of
Tennessee to obtain the whole sequence of the 16S rRNA gene using primers 63f and
1387r. The polygraph of the sequences were then processed using the program
Chromas that visualizes the quality of a sequence and allow for the selection of only the
best segment of the sequence to be used for identification. The best sequence was then
submitted to an online database, Ribosomal Database Project (RDP)
(http://rdp.cme.msu.edu) that compares it to a number of bacterial DNA sequences. The
program then identifies the genus of the unknown bacterium based on sequence
similarity to known 16S rRNA segments and estimates the 20 closest species matches
and their percentage similarities. The identified isolates were stored at -80 ᵒC.

Identification of Cultured-milk Isolates by API 50 System
The milk isolates were further identified to the species level by carbohydrate
metabolism using the API 50 system (bioMerieux sa 69280 Marcy l’Etoile - France)
Colonies on overnight anaerobic culture plates were suspended in 2 mL of distilled
water to prepare a heavy suspension. Two milliliters of bacterial suspension of isolates
with turbidity equivalent to number 2 McFarland standard was prepared by adding drops
of the bacterial suspension to distilled water. An ampule of API 50 medium for
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Staphylococcus and Lactobacillus was then opened and twice the number of drops that
prepared the 2 McFarland suspension were transferred into it and mixed by vortexing.
The reference numbers of the isolates were then recorded on the API 50 strips and the
tubes filled with the inoculum. The tubes were covered with sterile mineral oil and
incubated anaerobically for a period as stipulated on the manufacturer’s manual.
Positive and negative tests were indicated by yellow and blue colorations respectively.

Stability of Bacterial Isolates to Digestive Tract Conditions in vitro

Effect of Acid Buffer on Viability of Milk Bacterial Isolates
The test in this study was done in vitro in pH2 1M HCl buffer over a period of 3
hours. This was to determine if the cells will survive in the acidic stomach condition
because gastric content is reported to measure at pH of about 1.0 to 2.0 (Antione,
2011), with transit period of about 3 to 4 hours (Smith & Morton, 2010). Five milliliters of
a 24-hour MRS or M17 broth cultures were centrifuged at 65 x g for 5 minutes. Cell
pellets were washed with sterile 1X PBS at pH7.4 and resuspended in 5 mL of 1X PBS.
The suspension of washed cells was divided into aliquots of 1 mL in microfuge
tubes and centrifuged at 65 x g for 5 minutes. The supernatant was decanted and the
pellet was resuspended in 1 mL of 1X PBS at pH2.0 and mixed by vortexing for 30
seconds. The suspension was then incubated at 37 ᵒC in the oxygen condition similar to
which the isolate was originally isolated. One microfuge tube containing 1 mL aliquot of
acidified cell suspension was taken at 5 s, 1 h, 2 h, and 3 h intervals and centrifuged at
65 x g for 5 minutes. The cell pellet was washed with 1 mL 1X PBS at pH7.4. The
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acidified cell pellet was then resuspended in 1mL of 1X PBS at pH7.4 and serially
diluted with 1X PBS at pH7.4 by 6-fold. Then 250 µL of the final dilution was inoculated
on agar plates of the medium on which the isolate was grown and incubated at 37 ᵒC for
24 hours to examine effect of low pH on viable cell count.

Effect of Acid Buffer and/or Bovine Bile on Growth of Milk Isolates
This test was conducted in vitro with surviving cells after incubation in pH2 buffer
for 3 hours. Cells in 1 mL aliquots of a 3-hour preacidified suspension were spun at 65
x g for 5 minutes and the pellets were then washed once with 1X PBS at pH7.4 and
then resuspended in 5 mL of fresh MRS or M17 broths that had been conditioned with
or without 0.3% dried unfractionated bile bovine (Sigma Aldrich Co. St. Louis, MO
63103 USA, Cat number B-3883). The broth cultures were then incubated in conditions
that were similar to those under which cells were isolated. Cells in similar volumes of
untreated culture broths were also washed with 1X PBS at pH7.4 and resuspended in
fresh broth as control or in 0.3% bile bovine conditioned broth to test the effect of bile
only on their growth. One milliliter of incubating culture of each test was drawn at 0, 1, 3,
6, and 9 hour intervals for determining the optical densities of the culture broth at 600
nm wave lengths with Gene Sys-10uv spectrophotometer (Thermo Electron corporation,
Madison, WI 53711, USA) (Gilliland & Walker, 1990; Toit et al., 1998).

Mucin Degradation Activity on Agarose Petri Dish
Mucin provides protection to the epithelium and therefore its degradation is
undesirable of probiotic bacteria. Failure to degrade mucin is considered a prerequisite
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for selection of probiotics strains (Zhou et al., 2001). The capacity of the isolates to
degrade mucin was assayed with partially purified porcine gastric mucin type III (Sigma
Aldrich Co. 3060 Spruce Street, St. Louis, MO 63103 USA, Sigma Cat. # M1778). The
medium was prepared by adding 0.5% (w/v) mucin to 1.5 % (w/v) medium B (7.5 g
Trypton, 7.5 g Casitone, 3.0 g Yeast extract, 5.0 g Meat extract, 5.0 g NaCl, 3.0 g
KH 2 PO 4 .H 2 O, 0.5 g KH 2 PO 4 , 0.5 g MgSO 4 .7H 2 O, 0.5 g Cysteine HCl, 0.02 g
Rasarurin, 0.5% mucin, 1.5% agarose and with or without 0.3% D-(+)- glucose). Five
microliters of a 24-hour viable bacterial culture was inoculated on agarose medium in a
petri dish and incubated at 37 ᵒC anaerobically for 72 hours. The plates were then
stained with 1% Amido black 10 B (Fair Lawn, New Jersey 07410) in 3.5 M acetic acid
for 30 minutes. The plates were then decolorized with 1.2 M acetic acid for 1 minute for
the mucin lysis zone (discolored halo) around the colony of positive test and positive
control (fecal flora) to appear. Negative control used in this study was Lactobacillus
casei (ATCC collection, Manassas, VA 20110 USA). The mucin degradation activity
was defined as the size of the mucinolytic zone around the colony (Zhou et al., 2001).

Antimicrobial Activity of Cultured-milk Isolates
The capacity of the strains to inhibit growth of representative intestinal pathogens
was determined. The culture broths of bacterial isolates at the exponential phase
(OD 600 of 0.5) were pelleted at 10,000 g for 30 minutes at 4 ᵒC. The supernatant fluid
was filtered using PVDF membrane; Millipore Millex –GV 0.22µm pore size (Fisher
scientific, Cat number SLGVR04NK) to remove any remaining bacterial cells in it.
Bacterial test strains including Escherichia coli, Klebsialla pneumonia, Enterococcus
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faecalis, Pseudomonas aeruginosa, and Enterobacter cloacae (ATCC collection,
Manassas, VA 20110 USA) were then cultured overnight in Thermo Scientific LB broth (
Fisher Scientific, Cat number BP 9722-500) and samples were inoculated on Thermo
scientific LB agar (Fisher Scientific, Cat R453632) plates using sterile cotton buds. A
sterile paper disc with diameter 8 mm was infused with 50 µL of the filter-sterilized spent
broth of each milk isolate and placed on the surface of agar plates that had been
inoculated with test strains. A disc infused with 50µl of fresh sterile broth was used as
control. The plates were then incubated at 37 ᵒC in aerobic condition for 48 hours and
inspected for zones of inhibition of growth of test strains around the disc. The diameter
of the halo around the disc was measured in millimeters as the amount of antimicrobial
activity of the bacterial isolates.

Sensitivity of Cultured Milk isolates to Antibiotics
The sensitivity of isolates to antibiotics was determined on MRS or M17 agar
plates using eight different antibiotic discs in a sensi-disc dispenser (BBL, Cockeysville,
Maryland 21030, USA). Antibiotics assayed included ampicillin (10 µg), bacitracin (10
IU/IE/UI), chloramphenicol (30 µg), erythromycin (15 µg), kanamycin (30 µg), penicillin
(10 IU/IE/UI), streptomycin (30 µg), and tetracycline (30 µg). The averages of two
readings of the zone of inhibition of growth around the disc were measured in
millimeters as the antibiotic sensitivity of isolates (Delgado, O’Sullivan, Fitzgerald, &
Mayo, 2007). Bacterial strains that harbor antibiotic resistance plasmids are considered
unsuitable for use as human or animal probiotics (Morelli & Wright, 1997; Saarela,
Mogensen, Fonden, Matto, & Mattila-Sandholm, 2000; Salminen et al., 1998).
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Effect of Bacterial Extracts on Mucin-3 and Mucin-4 Production in CCD 841 CoN Cells

Human Colon CCD 841CoN Cell Culture
Human colon 841 CoN cell line was purchased from the American Typed Culture
Collections and grown in DMEM complete medium with 10% FCS and 5% antibiotics
(100 U/mL penicillin G, 100 mg/mL streptomycin sulfate). The culture was seeded in a
biological safety II cabinet in sterile T75 flasks and incubated at 37 ᵒC in a humidified
atmosphere with 5% CO 2 . Culture media were changed after every 72 h until cells
reached 70% confluence. The cells were then detached and harvested following
trypsinization with 3mL of 1X trypsin-EDTA (Gibco, Grand Island, NY) at 37 ᵒC in about
4 minutes. Fresh complete DMEM medium was added to the detached cells to
deactivate the effect of trypsin-EDTA. The cell suspension was then transferred into a
50 mL centrifuge tube and centrifuged at 125 x g for 5 minutes. Cell pellets were rinsed
with PBS 1X pH7.4 and resuspended in 5 mL DMEM storage medium containing 40%
FCS and 10% DMSO. Cells were counted with haemocytometer and dispensed into
aliquots in 1 mL microfuge tubes for storage in liquid nitrogen.

Treatment of Human Colon CCD 841 CoN Cells with Bacterial Extracts
Human colon CCD 841 CoN cells were seeded at cell density of 1X105 per well
T75 flask containing 10 mL of complete DMEM media and allowed for 8 days to grow to
about 70% confluence. The media were aspirated and the cells were treated with
complete DMEM media containing either 10% vehicle (1X PBS pH7.4) or 10% bacterial
extracts; (bacterial cytoplasmic fractions (BCF), bacterial cytoplasmic fractions and
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culture spent broth mixture (BCM), bacterial spent broth (BSB); for 24 h at 37 ᵒC in 5%
CO 2 . The cells were trypsin harvested following microcentrifugation at 125x g for 8
minutes and 4 ᵒC and washed twice with 1X PBS7.4 and used for extraction of proteins.

Human Colon CCD 841 CoN Whole Cell Extract
To prepare the colon whole cell extract, the treated cells were detached by
trypsinization and transferred into microfuge tube and washed twice with 1X PBS pH7.4.
The cells were then suspended in a 50 mL 5% protease inhibitor cocktail lysis buffer
(Calbiochem, EMD Chemicals, Inc. San Diego, CA 92121, Cat. number 539134) and
incubated on ice for 3 h to lyse the cells. The protein concentration of the lysed whole
cell extract determined using BCATM protein assay kit (Pierce, Lot number HG104261).
The concentration of all the protein extracts were standardized to 2.0 µg/µL and stored
at -20ᵒC.

Western Blot Analysis
Aliquots (15 µg) of equal quantities of homogenized protein extracts were
solubilized in equal volumes of loading buffer (3.55 mL of deionized water, 1.25 mL of
0.5 M Tris-HCl, pH6.8, 2.5 glycerol, 2 mL 10% (w/v) SDS, 0.2 mL 0.5% (w/v)
bromophenol blue, for the stock sample and 50 µL of 2- beta mercaptoethanol added to
950 µL of stock sample to prepare loading buffer each time ready to use it). The
proteins were then loaded into 4 – 20% Mini-protean® TGCTM gel (Bio-Rad, Cat
number 456-1096) and separated by sodium dodecyl sulfate -polyacrylamide gel
electrophoresis in 1X Tris-glycine SDS-PAGE running buffer (30.0 g tris base, 144 g
44

glycine, 10 g sodium dodecyl sulfate, in 1 liter of double distilled water) using Mini
Protean® Tetra cell electrophoresis tank (Bio-Rad laboratories, Inc., Cat number 1658035) and power was supplied from Max Power 100VA (Fisher Scientific, 2555 Keeper
Boulevard Dubuque, Iowa 52001). After 1 h of electrophoresis at 200mV, 40mA, the
protein on the gel was transferred onto immobilon transfer membrane, pore size 0.45
µm (Millipore Corporation, Billerica, MA 01821, Cat. number IPVH00010) in 1X western
blot transfer buffer (30.0 g tris base, 144 g glycine in 1 liter of double distilled water).
The membrane was removed from the assembly and quenched with 5% non-fat dry milk
in 1X Tris-buffered saline tween-20 pH7.4 (88 g NaCl, 2 g KCl, 30 g tris base, 5 mL
tween-20 in 1 liter of double distilled water with pH adjusted to 7.4). The membrane was
then incubated with primary antibodies against Muc-3 (rabbit anti-muc3, Jackson
Immunoresearch lab; www.jacksonimmuno.com) and Muc4 (mouse anti-muc4, Jackson
Immunoresearch laboratory; www.jacksonimmuno.com) at 4 ᵒC on shaker for 6 h. The
membrane was washed three times for 15 minutes each with 1X TBST (10 mM Tris-Cl,
pH 7.4, 150 mM NaCl, 0.05% Tween-20) and immunoblotted with corresponding
secondary antibodies. Donkey antirabbit IgG conjugate was incubate with Muc3 and
donkey antimouse IgG conjugate was used for Muc4. The membranes were incubated
on shaker for 1h at room temperature. The membrane were further washed three times
for 15 minutes each with 1x TBST and prepared for film development. A 1:1 ratio of
Supersignal West Femto reagents were pipetted into microfuge tube and mixed by
hand. The mixture was added to the immobilon transfer membrane on a transparency
and covered by another transparency and then exposed to a radiogragh
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(chemiluminescent signals) to develop using Proteinsimple Flour chem M (3040
Oakmead Village Drive, Santa Clara, CA 95051) (Mattar et al., 2002).
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CHAPTER 3

RESULTS
Identification of Cultured-milk Isolates by PCR
Fourteen isolates were identified from the PCR sequences of the 16S rRNA
gene. They included 4 Lactobacillus sp., 4 Bacillus sp., 4 Staphylococcus sp., and 2
Acetobacter sp (Table 1).
Table 1
Identification of Cultured-milk Isolates by PCR
Plate
Identification
Number
MRS-4AN

Suggested name for
bacterial isolate
Lactobacillus rhamnosus 1a

Percentage Number of unique
similarity
oligos submitted for
query
0.998
1054

MRS-6AN

Lactobacillus rhamnosus 2

0.994

993

M17-3AN
M17-4AN

Lactobacillus paracasei
Lactobacillus rhamnosus 3

0.994
0.935

993
553

M17-1AE
M17-2AE

Bacillus pumilus 1
Bacillus pumilus 2

1.0
1.0

1135
1098

M17-3AE
M17-4AE

Bacillus safensis 1
Bacillus safensis 2

0.998
1.0

986
1201

M17-1AN

Staphylococcus caprae

0.996

956

M17-2AN
MRS-4AE

0.994
0.995

1197
1002

1.0

1193

MRS-1AE

Uncultured bacterium b
Staphylococcus
epidermidis 1
Staphylococcus
epidermidis 2
Acetobacter tropicalis 1

1.0

986

MRS-2AE

Acetobacter tropicalis 2

0.993

993

MRS-5AE

Cultured milk isolates identified from PCR sequence match for 16S rRNA gene. a
Numbers represent Isolates that differ in colony morphology but were suggested to
have the same genus or species identity. b The isolate was identified to the genus level
as Staphylococcus but no name was suggested for it by the system.
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Identification of Cultured-milk Isolates by API 50 System
Eight isolates were identified from the API assay. They included 2 Lactobacillus
rhamnnosus, 2 Lactobacillus paracasei, 1 Staphylococcus aureus, 1Staphylococcus
sciuri, and 2 Staphylococcus epidermidis (Table 2).

Table 2
Identification of Cultured-milk Isolates by API System
Plate identification
number

Suggested name for bacterial
isolate a

Percentage similarity

MRS-4AN

Lactobacillus rhamnosus 1b

99.6

MRS-6AN

Lactobacillus rhamnosus 2

99.8

M17-3AN

Lactobacillus paracasei 1

99.3

M17-4AN

Lactobacillus paracasei 2

95.7

M17-1AN

Staphylococcus aureus

100

M17-2AN

Staphylococcus sciuri

99.8

MRS-4AE

Staphylococcus epidermidis 1

99.7

MRS-5AE

Staphylococcus epidermidis 2

99.6

a

Only Lactobacillus and Staphylococcus isolates were identified by the API assay.

b

Isolates differ in colony morphology but were suggested to have the same species
identity.
pH of Cultured-milk Isolates Broth Culture
When the pH of broth cultures of the bacterial isolates was measured at 12 h and
24 h after incubation, the pH of the Lactobacillus rhamnosus isolates was in the range
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of 3.9 to 4.2. Lactobacillus paracasei isolates maintain a slightly acidic pH around
pH6.7 to 6.9. Bacillus spp maintained almost neutral pH condition of about pH7.0 to
7.1. Staphylococcus aureus maintained slightly acidic pH of ranging 6.7 to 6.8.
Staphylococcus sciuri maintained its culture pH around 6.8 to 6.9. Staphylococcus
epidermidis 1 had its pH ranging from 4.9 to 5.9. Staphylococcus epidermidis 2 had its
pH ranging from 5.7 to 5.9 and the Acetobacter isolates had their pH ranging from 5.6 to
6.2 (Table 3).
Table 3
pH of Broth Culture of Bacterial Isolates
Bacterial isolates a

pH of broth culture after pH of broth culture after
12 h incubation

24 h incubation

Lactobacillus rhamnosus 1

4.2

3.9

Lactobacillus rhamnosus 2

4.2

4.0

Lactobacillus paracasei 1

6.8

6.9

Lactobacillus paracasei 2

6.7

6.9

Bacillus pumilus 1

7.1

b

Bacillus pumilus 2

7.0

7.1

Bacillus safensis 1

7.1

7.1
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Table 3 (continued)
Bacillus safensis 2

7.0

7.1

Staphylococcus aureus

6.8

6.7

Staphylococcus sciuri

6.8

6.9

Staphylococcus epidermidis 1

5.9

4.9

Staphylococcus epidermidis 2

5.9

5.7

Acetobacter sp 1

6.2

5.8

Acetobacter sp 2

6.2

5.6

a

Two milliliters of broth culture was taken for measurement of pH at each time.

b

pH of the isolate was not measured at 24 h because the flask containing the culture

got broken.

Effect of Acid Buffer on Viability of Bacterial Isolates
The viability of Lactobacillus, Staphylococcus, and Acetobacter isolates greatly
diminished when the cultures were exposed to pH2 acid buffer and grown on Petri dish.
Bacillus isolates were stable when the cells were exposed to pH2 acid buffer. Viability
was examined by inoculating sample of the treated culture at 1 hour interval on Petri
dishes. The plates were incubated for 24h and the colonies that form on the plates were
counted as viable colony forming units (cfu). All colonies that seemed to have
overlapped in space were counted as one colony (Table 4).
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Table 4
Effect of Acid Buffer on Viability of Bacterial Isolates
Bacterial isolates

Viability of cells (x106 cfu/mL)
0h

1h

2h

3h

Lactobacillus rhamnosus 1a

478

13

12

0

Lactobacillus rhamnosus 2

598

16

10

0

Lactobacillus paracasei 1

786

2

0

0

Lactobacillus paracasei 2

688

6

0

0

Bacillus pumilus 1

978

914

918

908

Bacillus pumilus 2

721

691

701

614

Bacillus safensis 1

488

394

379

408

Bacillus safensis 2

892

789

778

698

Staphylococcus aureus

456

38

0

0

Staphylococcus sciuri

374

12

0

0

Staphylococcus epidermidis 1

152

14

8

0

Staphylococcus epidermidis 2

116

20

11

0

Acetobacter sp 1

764

0

0

0

Acetobacter sp 2

144

0

0

0

a

Isolates differ in colony morphology but were suggested to have the same species

identity.
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Effect of Acid Buffer and/or Bovine Bile on Growth of Lactobacillus Isolates
The growth of Lactobacillus paracasei isolate 1 that had been exposed to pH2 acid
buffer for 3h then grown in fresh media declined greatly (Figure 3). The growth of the
isolate also declined when it was exposed to pH2 acid buffer for 3 h and then grown in
0.3% bile-conditioned media. However, when the untreated culture of Lactobacillus
paracasei isolate 1 was grown in 0.3% bile-conditioned media, the growth of the isolate
gently increased through the 9 h period.
Similarly, the growth of Lactobacillus paracasei isolate 2 that had been exposed to
pH2 acid buffer for 3 h and then grown in 0.3% bile-conditioned media declined through
the 9 h period (Figure 4). The growth of the isolate remained static when the cells were
exposed to pH2 acid buffer for 3 h and then grown in fresh broth. However, when the
untreated Lactobacillus paracasei isolate 2 was grown in 0.3% bile-conditioned media,
the growth of the isolate increased gently through the 9 h period.
The growth of Lactobacillus rhamnosus isolate 1 and 2 that had been exposed to
pH2 acid buffer for 3 h and then grown in fresh media remained static (Figure 5 and 6
respectively). However, the growths of the isolates declined when they were exposed to
pH2 acid buffer for 3 h and then grown in 0.3% bile-conditioned media. When the
untreated Lactobacillus rhamnosus isolates 1 and 2 were grown in 0.3% bileconditioned media, their growths remained static through the 9 h period. However, the
growth of untreated control Lactobacillus paracasei and Lactobacillus rhamnosus
isolates increased rapidly when the isolates were cultured in fresh broth.
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Figure 3. Effect of Acid Buffer and/or Bovine Bile on Growth of L. paracasei Isolate 1.
Bacteria were exposed to different treatments (pH2 acid buffer then untreated broth;
pH2 acid buffer then 0.3% bovine bile conditioned broth; 0.3% bovine bile conditioned
broth; unconditioned broth for control) and grown for 9 h in conditions similar to which
the isolate had been isolated.
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Figure 4. Effect of Acid Buffer and/or Bovine Bile on Growth of Lactobacillus paracasei
Isolate 2. Bacteria were exposed to different treatments (pH2 acid buffer then untreated
broth; pH2 acid buffer then 0.3% bovine bile conditioned broth; 0.3% bovine bile
conditioned broth; unconditioned broth for control) and grown for 9 h in conditions
similar to which the isolate had been isolated.
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Figure 5. Effect of Acid buffer and/or Bovine Bile on Growth of Lactobacillus rhamnosus
Isolate 1. Bacteria were exposed to different treatments (pH2 acid buffer then untreated
broth; pH2 acid buffer then 0.3% bovine bile conditioned broth; 0.3% bovine bile
conditioned broth; unconditioned broth for control) and grown for 9 h in conditions
similar to which the isolate had been isolated.
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Figure 6. Effect of Acid Buffer and/or Bovine Bile on Growth of Lactobacillus rhamnosus
Isolate 2. Bacteria were exposed to different treatments (pH2 acid buffer then untreated
broth; pH2 acid buffer then 0.3% bile conditioned broth; 0.3% bile conditioned broth;
unconditioned broth for control) and grown for 9h in conditions similar to which the
isolate had been isolated.
Effect of Acid Buffer and/or Bovine Bile on Growth of Bacillus Isolates
The growth of Bacillus pumilus isolate 1 that had been exposed to pH2 acid buffer
for 3 h and then grown in 0.3% bovine bile-conditioned media declined rapidly in the first
1 h and increased gently through the next 8 h period (Figure 7). When the isolate was
exposed to pH2 acid buffer for 3h and then grown in fresh broth, its growth increased
gently through the 9h period. The growth of untreated Bacillus pumilus isolate 1
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declined gently in the first 1 h and increased gently through the next 8 h when the
isolate was grown in 0.3% bovine bile-conditioned media.
The growth of Bacillus pumilus isolate 2 that had been exposed to pH2 acid buffer
for 3 h and then grown in 0.3% bovine bile-conditioned media declined gently in the first
1 h and then increased gently through the next 8 h period (Figure 8). When the isolate
was exposed to pH2 acid buffer for 3 h and then grown in fresh broth, its growth
increased gently through the 9 h period. However, the growth of untreated Bacillus
pumilus isolate 2 declined gently in the first 1 h and increased gently through the next 8
h period when the isolate was grown in 0.3% bovine bile-conditioned media.
The growth of Bacillus safensis isolate 1 that had been exposed to pH2 acid buffer
for 3 h and then grown in 0.3% bovine bile-conditioned media remained static through
the 9 h period (Figure 9). When the isolate was exposed to pH2 acid buffer for 3h and
then grown in fresh broth, its growth increased gently in the first 1 h and declined gently
through the next 8 h period. The growth of the untreated Bacillus safensis isolate 1
remained static when it was grown in 0.3% bovine bile-conditioned media.
The growth of Bacillus safensis isolate 2 that had been exposed to pH2 acid buffer
for 3 h and then grown in 0.3% bovine bile-conditioned media decreased gently in the
first 1 h and then remained static through the next 2 h and begun to increase gently
through the next 6 h period (Figure 10). When the isolate was exposed to pH2 acid
buffer for 3 h and then grown in fresh broth, the growth of the isolate increased gently
through the 9 h period. The growth of the untreated Bacillus safensis isolate 2 also
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decreased gently in the first 1 h and begun to increase in the following hours when it
was grown in 0.3% bovine bile-conditioned media. The growth of untreated control
Bacillus pumilus and Bacillus safensis isolates increased rapidly when the isolates were
cultured in fresh media.

Figure 7. Effect of Acid Buffer and/or Bovine Bile on Growth of Bacillus pumilus Isolate
1. Bacteria were exposed to different treatments (pH2 acid buffer then untreated broth;
pH2 acid buffer then 0.3% bovine bile conditioned broth; 0.3% bovine bile conditioned
broth; unconditioned broth for control) and grown for 9h in conditions similar to which
the isolate had been isolated.
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Figure 8. Effect of Acid Buffer and/or Bovine Bile on Growth of Bacillus pumilus Isolate
2. Bacteria were exposed to different treatments (pH2 acid buffer then untreated broth;
pH2 acid buffer then 0.3% bovine bile conditioned broth; 0.3% bovine bile conditioned
broth; unconditioned broth for control) and grown for 9 h in conditions similar to which
the isolate had been isolated.
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Figure 9. Effect of Bile acid Buffer and/or Bovine Bile on Growth of Bacillus safensis
Isolates 1. Bacteria were exposed to different treatments (pH2 acid buffer then
untreated broth; pH2 acid buffer then 0.3% bovine bile conditioned broth; 0.3% bovine
bile conditioned broth; unconditioned broth for control) and grown for 9 h in conditions
similar to which the isolate had been isolated.
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Figure10. Effect of Acid Buffer and/or Bovine Bile on Growth of Bacillus safensis Isolate
2. Bacteria were exposed to different treatments (pH2 acid buffer then untreated broth;
pH2 acid buffer then 0.3% bovine bile conditioned broth; 0.3% bovine bile conditioned
broth; unconditioned broth for control) and grown for 9 h in conditions similar to which
the isolate had been isolated.
Effect of Bcid Buffer and/or Bovine Bile on Growth of Staphylococcus Isolates
The growth of Staphylococcus aureus that had been exposed to pH2 acid buffer for
3 h and then grown in 0.3% bovine bile-conditioned media remained static over the first
3 h and decreased gently through the next 6 h period (Figure 11). When the isolate was
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exposed to pH2 acidic buffer for 3 h and then grown in fresh broth, the growth remained
static through the 9 h period. The growth of untreated Staphylococcus aureus
increased rapidly when the isolate was cultured in 0.3% bovine bile-conditioned media.
The growth of Staphylococcus sciuri isolate that had been exposed to pH2 acid
buffer for 3 h and then cultured in 0.3% bovine bile-conditioned media remained static
for the first 3 h and begun to decrease gently through the next 6 h period (Figure 12).
When the Staphylococcus sciuri isolate was exposed to pH2 acid buffer for 3 h and then
cultured in fresh broth, its growth remained static through the 9 h period whereas the
growth of its untreated culture increased rapidly when it was grown in 0.3% bovine bileconditioned media.
The growth of Staphylococcus epidermidis isolates 1 and 2 that had been exposed
to pH2 acid buffer for 3 h then cultured in 0.3% bile-conditioned media increased rapidly
through the 9 h period (Figure 13 and 14 respectively). When the isolates were exposed
to pH2 acidic buffer for 3h and then cultured in fresh broth, their growth also increased
rapidly through the 9-h period and the growth of untreated Staphylococcus epidermidis
isolate 1 and 2 also increased rapidly when they were grown in 0.3% bile-conditioned
media. The growths of untreated control Staphylococcus aureus, Staphylococcus sciuri
and Staphylococcus epidermidis isolates 1 and 2 all increased rapidly when the isolates
were cultured in fresh media.
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Figure 11. Effect of Acid Buffer and/or Bovine Bile on Growth of Staphylococcus aureus.
Bacteria were exposed to different treatments (pH2 acid buffer then untreated broth;
pH2 acid buffer then 0.3% bovine bile conditioned broth; 0.3% bovine bile conditioned
broth; unconditioned broth for control) and grown for 9 h in conditions similar to which
the isolate had been isolated.
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Figure 12. Effect of Acid Buffer and/or Bovine Bile on Growth of Staphylococcus sciuri.
Bacteria were exposed to different treatments (pH2 acid buffer then untreated broth;
pH2 acid buffer then 0.3% bovine bile conditioned broth; 0.3% bovine bile conditioned
broth; unconditioned broth for control) and grown for 9 h in conditions similar to which
the isolate had been isolated.
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Figure 13. Effect of Acid Buffer and/or Bovine bile on Browth of Staphylococcus
epidermidis Isolate 1. Bacteria were exposed to different treatments (pH2 acid buffer
then untreated broth; pH2 acid buffer then 0.3% bovine bile conditioned broth; 0.3%
bovine bile conditioned broth; unconditioned broth for control) and grown for 9 h in
conditions similar to which the isolate had been isolated.
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Figure 14. Effect of Acid Buffer and/or Bovine Bile on Growth of Staphylococcus
epidermidis Isolate 2. Bacteria were exposed to different treatments (pH2 acid buffer
then untreated broth; pH2 acid buffer then 0.3% bovine bile conditioned broth; 0.3%
bovine bile conditioned broth; unconditioned broth for control) and grown for 9 h in
conditions similar to which the isolate had been isolated.
Viability of Lactobacillus Isolates After a 9 h Period of Exposure to Acid Buffer and/or
Bovine Bile
Lactobacillus isolates were further examined for viability after exposing the cells
to pH2 acid buffer and/or 0.3% bovine bile over a 9 h period. Cultures of the different
treatments were heavily inoculated on four quadrants of agar plates using sterile cotton
swabs and incubated in conditions similar to those under which the isolates had been
isolated. The identities of the quadrants were: culture exposed to PBS pH7.4 and grown
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in fresh broth for control; culture exposed to PBS pH7.4 and grown in 0.3% bovine bile
conditioned broth; culture exposed to pH2 acid buffer and grown in fresh broth and
culture exposed to pH2 acid buffer and then grown in 0.3% bovine bile conditioned
broth. The Lactobacillus paracasei isolates that had been exposed to PBS pH7.4 and
cultured in 0.3% bovine bile conditioned broth maintained their viability. However, when
the isolates were exposed to pH2 acid buffer and then cultured in fresh broth or 0.3%
bovine bile conditioned broth, their viabilities diminished greatly. Similarly the viability of
Lactobacillus rhamnosus isolates that had been exposed to pH2 acid buffer and
cultured in 0.3% bovine bile conditioned broth diminished greatly. The viability of
untreated Lactobacillus rhamnosus isolates that had been cultured in 0.3% bovine bile
conditioned media also diminished greatly (Figure 15).

67

Figure 15. Viability of Lactobacillus Isolates After a 9 h Period of Exposure to Acid
Buffer and/or Bovine Bile. PBS is control.
Viability of Acetobacter Isolates After a 9 h Period of Exposure to Acid Buffer and/or
Bovine Bile
Acetobacter isolates were further examined for viability after the exposure of the
cells to pH2 acidic buffer and/or 0.3% bovine bile over a 9 h period. Cultures of the
different treatments were heavily inoculated on four quadrants of agar plates using
sterile cotton swabs and incubated in conditions similar to those under which the
isolates had been isolated. The identities of the quadrants were: culture exposed to PBS
pH7.4 and grown in fresh broth for control; culture exposed to PBS pH7.4 and grown in
0.3% bovine bile conditioned broth; culture exposed to pH2 acid buffer and grown in
fresh broth and culture exposed to pH2 acid buffer then grown in 0.3% bovine bile
conditioned broth. The Acetobacter isolates that had been exposed to PBS pH7.4 and
grown in 0.3% bovine bile conditioned broth maintained their viability. When
Acetobacter isolates were exposed to pH2 acid buffer and then cultured in fresh broth,
the viability of cells completely diminished. When exposed cells were culture in 0.3%
bovine bile conditioned broth, the viability of the cells also diminished greatly (Figure
16).
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Figure 16. Viability of Acetobacter Isolates After a 9 h Period of Exposure to Acid Buffer
and/or Bovine Bile. PBS is control.
Viability of Bacillus Isolates After a 9 h Period of Exposure to pH2 Acid Buffer and/or
Bovine Bile
Bacillus isolates were further examined for viability after exposing the cells to pH2
acid buffer and/or 0.3% bovine bile over a 9 h period. Cultures of the different
treatments were heavily inoculated on four quadrants of agar plates using sterile cotton
swabs and incubated in conditions similar to those under which the isolates had been
isolated. The identities of the quadrants were: culture exposed to PBS pH7.4 and grown
in fresh broth for control; culture exposed to PBS pH7.4 and grown in 0.3% bovine bile
conditioned broth; culture exposed to pH2 acid buffer and grown in fresh broth and
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culture exposed to pH2 acid buffer then grown in 0.3% bovine bile conditioned broth.
Bacillus pumilus and Bacillus safensis isolates that had been exposed to PBS pH7.4
and cultured in 0.3% bovine bile conditioned broth maintained their viability. The
isolates also maintained their viability when the cells were exposed to pH2 acid buffer
and then cultured in fresh broth or 0.3% bovine bile conditioned broth (Figure 17).

Figure 17. Viability of Bacillus Isolates After a 9 h Period of Exposure to Acid Buffer
and/or Bovine Bile. PBS is control.
Viability of Staphylococcus Isolates After a 9 h Period of Exposure to Acid Buffer and/or
Bovine Bile
The viability of Staphylococcus isolates were further examined after exposing the
cells to pH2 acid buffer and/or 0.3% bovine bile over a 9-h period. Cultures of the
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different treatments were heavily inoculated on four quadrants of agar plates using
sterile cotton swabs and incubated in conditions similar to those under which the
isolates had been isolated. The identities of the quadrants were: culture exposed to
PBS pH7.4 and grown in fresh broth for control; culture exposed to PBS pH7.4 and
grown in 0.3% bovine bile conditioned broth; culture exposed to pH2 acid buffer and
grown in fresh broth and culture exposed to pH2 acid buffer then grown in 0.3% bovine
bile conditioned broth. The Staphylococcus epidermidis isolates had been exposed to
PBS pH7.4 and grown in 0.3% bovine bile conditioned broth maintained their viability.
The isolates also maintained their viability when the cells were exposed to pH2 acid
buffer and then cultured in fresh broth or 0.3% bovine bile conditioned broth (Figure 18).
The viability of Staphylococcus aureus and Staphylococcus sciuri isolates remained
stable when their cells were exposed to PBS pH7.4 and cultured in 0.3% bovine bile but
greatly diminished when the cells were exposed to pH2 acid buffer and then cultured in
fresh broth or in 0.3% bovine bile conditioned broth (Figure 18).
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Figure 18. Viability of Staphylococcus Isolates After a 9 h Period of Exposure to Acid
Buffer and/or Bovine Bile. PBS is control.
Mucin Degradation Assay on Agarose Petri Dish
When 5µL of a 24-hour culture of milk isolates were spotted on agarose medium
B containing 0.5% partially purified mucin from porcine stomach and without glucose,
only Staphylococcus sciuri isolate degraded the mucin. A clear zone around the colony
after staining the agarose plate with 1% Amido black 10 B and washing with 2.5 M
acetic acid for 1 minute was considered positive for mucin degradation activity (Figure
19). The amount of mucin degraded was measured in terms of the size of the clear
zone around the colony of positive test in millimeters. The zone of mucin degradation
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measured was14 mm for Staphylococcus sciuri isolate compared to 13 mm for the fecal
flora positive control.

Figure 19. Mucin Degradation Activity on Agarose Medium B Petri Dish. Clear zone
around colonies were considered positive for mucin degradation.
Antimicrobial Activity of Filter-sterilized Spent-broth
Lactobacillus rhamnosus isolate 1 inhibited the growth of Escherichia coli,
Enterococcus faecalis, and Psuedomonas aeruginosa bacterial test strains. The
Lactobacillus rhamnosus isolate 2 inhibited the growth of Enterococcus faecalis and
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Pseudomonas aeruginosa. Lactobacillus paracasei isolate 1 did not inhibit the growth of
any of the indicator strains and the Lactobacillus paracasei isolate 2 inhibited the growth
of Escherichia coli and Pseudomonas aeruginosa. Acetobacter isolates presented
antimicrobial activity against only Enterococcus faecalis. All Bacillus spp isolates did not
inhibit the growth of any of the bacterial indicator strains. Staphylococcus epidermidis
isolate 1 inhibited the growth of Enterococcus faecalis and Pseudomonas aeruginosa.
However, the zone of inhibition produced by the Staphylococcus epidermidis isolate 1
appeared as a hazy zone around the disc indicating that some of the cells of the
indicator strains were alive. The Staphylococcus epidermidis isolate 2 did not show sign
of inhibiting the growth of any of the indicator strains. Staphylococcus sciuri isolate
inhibited the growth of Escherichia coli and Staphylococcus aureus isolate did not inhibit
the growth of any of the indicator strains (Table 5).
Table 5
Antimicrobial Activity of Filter-sterilized Spent-broth of Isolate
Milk isolates

Acetobacter 1
Acetobacter 2
Staphylococcus aureus
Staphylococcus sciuri
Staphylococcus epidermidis1
Staphylococcus epidermidis2
Bacillus pumillus 1
Bacillus pumillus 2
Bacillus safensis 1
Bacillus safensis 2
Lactobacillus rhamnosus 1
Lactobacillus rhamnosus 2
Lactobacillus paracasei 1
Lactobacillus paracasei 2

Antimicrobial activity of milk isolates against bacterial test strains
measured as diameter of zone of inhibition in millimeters a
E. coli E. cloacae E. faecalis K. pneumonia P. aeruginosa
0
0
12
0
10c
0
0
10
0
10
0
0
0
9
0
11
10
0
9
0
9
0
14
0
18b
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
9
14
9
14
10
9
12
9
12
0
0
0
10
10
12
10
10
0
12
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a

Inhibition of bacterial test strains (E. coli, K. pneumonia, E. faecalis, P. aeruginosa,

and E. cloacae) measured as diameter for zone of inhibition of growth of test strain in
millimeters around filter paper disc infused with 50µL of filter-sterilized spent broth of
isolates. Diameter of paper disc was 8mm.b Zone of inhibition around disc appeared
hazy due to some growth of the indicator strain. c Zone sizes of 9 or 10 mm were not
considered significant.
Sensitivity of Cultured-milk Isolates to Antibiotics
Lactobacillus rhamnosus, Staphylococcus aureus and Bacillus safensis isolates
showed susceptibility to all the eight antibiotics tested. Lactobactocillus paracasei
showed sensitivity to only kanamycin, bacitracin and streptomycin. Bacillus pumilus and
Staphylococcus epidermidis demonstrated resistance to all the eight antibiotics tested.
Acetobacter sp showed susceptibility to only ampicillin, kanamycin, and streptomycin
(Table 6).
Table 6
Sensitivity of Cultured-milk Isolates to Antibiotics
Milk isolates

Acetobacter 1
Acetobacter 2
Staphylococcus aureus
Staphylococcus sciuri
Staphylococcus epidermidis1
Staphylococcus epidermidis2
Bacillus pumillus 1

Sensitivity of milk isolates to antibiotics measures as zone of
inhibition of isolates around antibiotic infused disc in
millimeters a b
A
B
C
E
K
P
S
T
0
0
0
0
20
0
10c
26
0
0
0
0
15
0
12
24
25
12
30
25
23
20
10
28
20
18
21
21
0
25
0
30
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
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Table 6 (continued)
Bacillus pumillus 2
Bacillus safensis 1
Bacillus safensis 2
Lactobacillus rhamnosus 1
Lactobacillus rhamnosus 2
Lactobacillus paracasei 1
Lactobacillus paracasei 2

0
27
25
28
30
25
20

0
9
9
15
12
0
0

0
22
20
27
28
25
29

0
30
27
32
30
15
22

0
18
17
10
9
0
0

0
32
30
28
30
20
20

0
13
15
9
9
0
0

0
25
26
32
32
20
26

Sensitivity was measured as zone of inhibition of growth of the isolate around antibioticinfused disc in millimeters. a Diameter of disc was 8mm. b Antibiotics are represented as:
A= ampicillin; B = Bacitracin; C = Chloramphenicol; E = Erythromycin; K = Kanamycin;
P = Penicillin; S = Streptomycin and T = Tetracycline. c Zone sizes of 9 and 10mm are
considered as resistant.
Effect of Bacterial Extracts on MUC4 and MUC3 Production in CCD 841 CoN Cells
MUC4 in human colon CCD 841 CoN cells increased when the cells were treated
with 10% bacterial cell fractions (BCF) of a Lactobacillus rhamnosus isolated from
cultured milk compared to the cells that were treated with control 1x PBS pH7.4. MUC4
was expressed in two bands a 250kD and 100kD subunits. The 250kD MUC4 band was
similar for both the control and experiment. The 100kD Muc4 band however showed
about six-fold increased expression in the cells that were exposed to the BCF as
compared to the cells that were exposed to control PBS. MUC 3 was expressed as a
single 75kD band and showed increased in level of about two-fold in the CDD 841 CoN
cells that were exposure to the 10% BCF (Figure 20).
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Figure 20. Western Blot Analysis of MUC4 and MUC3 Expression Levels in Normal
Colon Cells. Total proteins (15 µg/lane) from human colon CCD 841 CoN cells treated
with 10% L. rhamnosus bacterial cytoplasmic fractions (BCF), or 10% Phosphate
buffered saline control (PBS) were separated by SDS-PAGE and transferred onto
immobillon transfer membrane. The membranes were immunoblotted with mouse antimuc4 and donkey antimouse IgG for Muc4 and rabbit anti-muc3 with donkey antirabbit
IgG for muc3 and exposed to radiogragh (chemiluminescent signals) to develop using
proteinsimple flour chem M.
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CHAPTER 4
DISCUSSION AND CONCLUSION
Discussion
This study was an examination of the bacterial composition of a Kenyan
traditional ‘Amabere amaruranu’ cultured milk preparation and determined the stability
of its isolates to digestive tract conditions, antimicrobial activity, sensitivity to antibiotics
and capacity to degrade mucins. The effect of bacterial cell fractions of a Lactobacillus
rhamnosus isolate that was isolated from the milk was also examined on human colon
841 CoN cells model for the production of MUC4 and MUC3 proteins. The goal of this
study was to determine the bacterial communities in the cultured milk and their probiotic
potentials. Although a wide variety of bacterial species and genera could have probiotic
effects, almost only lactobacilli belonging to Lactic acid bacterial (LAB) and
Bifidobacterial groups are mostly found in commercial use (Reid et al, 2008; Shah,
2007). Other bacterial communities in milk could also possibly have probiotic potentials.
Bacteria in dairy products and gut microbiota are common sources of screening for
probiotic strains. Because the bacterial composition of ‘Amabere amaruranu’ cultured
milk preparation has not been reported, it was a suitable source of screening for
potential novel probiotics strains.
Fourteen bacteria isolates with distinct colony and cell morphology were isolated
from the cultured milk sample. The isolates were identified by comparing the sequences
of the 16S rRNA gene of isolates to that of known bacteria species. The isolates
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included 4 Lactobacillus isolates, 2 Acetobacter spp, 4 Bacillus isolates, and 4
Staphylococcus isolates. The program used for comparing the gene sequences of
bacterial isolates for the identification could reliably identify the organisms to only the
genus level. In view of that, some of the isolates were further identified using a
biochemical method through API 50 system that compared the biochemical
characteristics of the isolates in various chemical indicators to that of known bacterial
strains. The bacterial isolates identified by this method included 2 Lactobacillus
rhamnosus isolates, 2 Lactobacillus paracasei isolates, 2 Staphylococcus epidermidis
isolates, 1 Staphylococcus aureus isolate, and 1 Staphylococcus sciuri isolate. The
Bacillus and Acetobacter isolates were not identified by the API assay due to lack of kits
specific for identifying the two genera.
Lactobacillus rhamnosus and Lactobacillus paracasei isolates were among the
dominant colonies in the milk sample, and that agreed with the reports by Abriouel,
Martin-Platero, Maqueda, Valdivia, and Martinez-Bueno (2008), Aponte, Fusco, Andolfi,
and Coppola (2008), and Randazzo et al. (2009) that they are among the common
bacterial strains in cheese and raw milk from cow, goat, and sheep. Other dominant
colonies that were found in the cultured milk sample were Acetobacter sp, Bacillus
pumilus, Bacillus safensis, and Staphylococcus epidermidis isolates. The Bacillus
isolates were found growing on only M17 agar plates that were incubated under aerobic
conditions. The Staphylococcus epidermidis isolates were found on only MRS agar
plates that were incubated under aerobic conditions. Bacillus pumilus has been reported
by Delbes et al. (2007) as a common component of cow milk and cheese and
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Stapylococcus epidermidis was reported by Callon et al. (2007) in goat’s milk.
Staphylococcus aureus and Staphylococcus sciuri isolates formed very few colonies on
the plates. Aponte et al. (2008) reported the isolation of Staphylococcus aureus in cow
milk cheese. Bacillus safensis, Acetobacter sp, and Staphylococcus sciuri isolates were
the bacterial populations that have not been reported in other milk or milk products but
were found in the ‘Amabere amaruranu’ cultured milk sample. The Staphylococcus
aureus and Staphylococcus sciuri that were found to have developed very few colonies
could possibly be contaminant species.
It was observed that the viability of Lactobacillus paracasei and Lactobacillus
rhamnosus isolates that were exposed to acidic buffer at pH2 greatly diminished after
the first 1 h of exposure. However, unexposed cells of the same isolates were viable
and very stable in 0.3% bovine bile conditioned media. Meanwhile, the pH of
unconditioned broth cultures of the Lactobacillus rhamnosus isolates taken at 12 and 24
hours after incubation was observed to be in the range of 3.9 to 4.2. This observation
suggested that Lactobacillus rhamnosus isolates could possibly withstand low pH
conditions in spite of the diminished viability and static growth pattern we observed for
the cells that had been exposed to pH2 conditions. Saarela et al. (2009) reported that
the viability of cells is growth phase dependent and that stationary phase cultures
seemed to be more tolerant to stress than cells at log phase. It is therefore possible that
the viability and growth of the Lactobacillus rhamnosus isolates could present a different
pattern depending on the growth phase at which the cultures were taken for the study.
Moreover, pH2 is an extreme pH condition of the human stomach that is usually
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attained during fasting and starvation (Antione, 2011). Therefore, it is possible that the
Lactobacillus rhamnosus isolates could survive the low pH conditions of the stomach
with appreciable rise in its pH during meals. It has also been mentioned that the
resistance of bacteria to bile salts varies among the lactic acid bacteria species and
strains (Xanthopoulos, 1997) and because the cultured milk isolates were not identified
to the strain level, we could not generalize that the growth responses to bile we
observed were representation of all Lactobacillus species.
Filter-sterilized spent broth of Lactobacillus rhamnosus and Lactobacillus
paracasei isolates were observed to have presented antimicrobial activity. They
inhibited the growth of Enterobacter faecalis, Escherichia coli, and Pseudomonas
aeruginosa indicator strains slightly. This is a positive trait for probiotic selection.
Because sterilized spent broths of the isolates were used for the test and not live
cultures, it is reasonable to suggest that the inhibitory effect could be one of the
suggestions that were proposed by Lewus et al. (1991) that resident microbiota and
probiotics may impede infection by directly antagonizing the growth of pathogens
through production of antimicrobial and antibacterial compounds such as bacteriocins.
Moreover, the antimicrobial activity of the isolates in this study, particular that of the
Lactobacillus rhamnosus isolates, could have been due to their inherent ability to lower
the pH of the spent broth to pH around 3.9 and 4.2 as we observed in this study. This
suggestion also agreed with the findings of Langhendries et al. (1995) that probiotics
may inhibit infections through reduction of the gut local pH by production of lactic acid.
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Testing and selecting bacterial strains that do not degrade mucins for probiotic
preparation is a check to avoid the use of bacterial strains that have the capacity to
degrade the protective mucus layer of the digestive tract (Zhou et al., 2001).
Lactobacillus paracasei and Lactobacillus rhamnosus isolates did not degrade mucin
and that made them suitable for probiotic preparation. We also observed that
Lactobacillus rhamnosus isolate were sensitive to all the eight antibiotics tested and the
Lactobacillus paracasei isolates were resistant to kanamycin, bacitracin, and
streptomycin. It is so appropriate that the Lactobacillus isolates in the cultured milk
demonstrated sensitivity to antibiotics. This is because the sensitivity of potential
probiotic strains to antibiotics has always been considered a positive trait. The use of
bacterial strains that show sensitivity to antibiotics for probiotics eliminates the
possibility of horizontal transfer of antibiotic resistance traits to potential pathogenic
intestinal dwellers (Collins et al., 1998).
The Staphylococcus aureus and Staphylococcus sciuri isolate that were
exposed to acidic buffer at pH2 greatly diminished in viability after the first 1 h of
exposure. However, unexposed cells of the same isolates were viable and showed
stable growth in 0.3% bovine bile conditioned media. The pH of culture broths of the
isolates at 12 h and 24 h after incubation was around 6.7 to 6.9. The Staphylococcus
aureus isolate did not show antibacterial activity and demonstrates sensitivity to all the
antibiotics tested and also did not degrade mucin. The Staphylococcus sciuri isolate
however degraded mucin and demonstrated resistance against bacitracin and
streptomycin. It also did not inhibit the growth of any of the indicator strains. Both
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exposed and unexposed Staphylococcus epidermidis isolates to pH2 acidic buffer
exhibited stability in fresh broth and in 0.3% bovine bile conditioned media. The pH of
culture broths of the isolates at 12 h and 24 h after incubation was around 4.9 to 5.9.
They showed resistance to all the 8 antibiotics tested and did not degrade mucin. One
of the Staphylococcus epidermidis isolates inhibited the growth of Enterococcus faecalis
and Pseudomonas aeruginosa, although the halo around the disc appeared hazy
indicating that some growth of the indicator strains was still possible. The bacteriostatic
effect observed could have been due to the ability of the isolate to lower its pH to 4.9.
Although the Staphylococcus isolates were stable to digestive tract conditions and
demonstrated some amount of antimicrobial activity against some of the indicator
strains, the strains could not recommended for probiotic preparation due various
reasons. For instance, the Staphylococcus sciuri isolate would be suitable for probiotic
preparations because of its mucinolytic ability and Staphylococcus epidermidis may not
also be recommended because its antibiotic resistance. The Acetobacter isolates that
had not been exposed to pH2 acidic buffer showed stability in 0.3% bovine bile
conditioned media but the growth of the exposed cells in fresh media declined greatly
and their viability also completely diminished. Acetobacter isolates were nonmucinolytic;
showed sensitivity to ampicillin, kanamycin, and streptomycin. One Acetobacter isolate
inhibited the growth of Enterococcus faecalis slightly. Both exposed and unexposed
Bacillus isolates demonstrated high viability and stability in fresh broth or in 0.3% bovine
bile conditioned media. This observation agreed with Sanders et al.’s (2003) report that
Bacillus sp are stable to stressful conditions due to an inherent ability for them to
produce metabolically inactive spores that are resistant to heat, drying, freezing, toxic
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chemicals, and radiations. The bacilli did not degrade mucin and did not present
antimicrobial activity against any of the bacterial indicator strains. However, Bacillus
pumilus demonstrated resistance against all the eight antibiotics tested but Bacillus
safensis was susceptible to all of them. Although the bacilli were very stable to digestive
tract conditions and maintained mucins, they may not be suitable probiotics because
they lacked antimicrobial activity and showed resistance against antibiotics.
The effect of cell fractions of one of the Lactobacillus isolates was examined in
human colon CCD 841 CoN cells for production of MUC4 and MUC3. This was done by
western blot analysis using whole cell extracts and antibodies specific for MUC4 and
MUC3. The treatment of CCD 841 CoN cells with10% cytoplasmic fractions of
Lactobacillus rhamnosus isolate brought about two-fold increase in the MUC3 protein
production in the cell models. MUC3 protein was expressed in low amount in the normal
colon cells model and as a single protein band with molecular weight of about 75kD.
The low amount of MUC3 protein expression as observed in the study agreed with
reports by Ho et al. (1993) and Van Klinken et al. (1995) that MUC3 is not highly
expressed in the colon. MUC4 protein was observed in normal colon cells model as two
protein bands with molecular weights of 250kD and 100kD bands. This observation is
similar to the findings of Choudhury et al. (2000) that mature forms of human MUC4
protein may exist at the cell surface as two associated protein subunits, a large
extracellular mucin type subunit (MUC4alpha) and a smaller, membrane-associated
growth factor-like subunit (MUC4beta). The treatment of CCD 841 CoN cells with 10%
cytoplasmic fraction of Lactobacillus rhamnosus resulted in an increase in the smaller
84

MUC4 protein band that has molecular weight of 100kD. It is interesting that
cytoplasmic fraction of the Lactobacillus rhamnosus isolate could stimulate the increase
in MUC4 protein levels in the normal colon cells. This observation agreed with Adams
(2010) that probiotic cell components can act as biological response modifiers. In this
regard, it might be suggestive that the administration of probiotic cytoplasmic fractions
in place of live cells in probiotic preparations may offer a safe alternative application of
the product and hopefully will resolve the concern for the possibility of probiotic sepsis
that was raised by Syndman (2008). The ability of cytoplasmic fractions of Lactobacillus
rhamnosus to up-regulate the expression of MUC4 protein in normal colon cell model
could be an essential therapeutic contribution of probiotic cell components to the
reduction of colorectal cancers. This hypothesis is informed by the findings made by
Moniaux et al. (2007) that MUC4 protein is implicated in the induction of ultrastructural
changes in the transformation of normal epithelium. It is also in line with the report of
Komatsu, Yee, and Carraway (2002) that MUC4 is implicated in reducing accessibility of
tumor cell surface antigens to cytotoxic immune cells, thus aiding in the evasion of the
host immune response. The characteristics of the bacterial isolates are summarized in
Table 7.
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Table 7
Summary of bacterial isolates characteristics
Bacterial
Isolates

Characteristics of bacterial isolates
Stability to
Stability Sensitivity to
acidic buffer to bile
antibiotics

Antimicrobial
activity

Nonmucinolytic

L. rhamnosus 1
L. rhamnosus 2
L. paracasei 1
L. paracasei 2
B. pumilus 1
B. pumilus 2
B. safensis 1
B. Safensis 2
S. aureus
S.sciuri
S. epidermidis 1
S. epidermidis 2
Acetobacter sp 1
Acetobacter sp 2

+
+
+
+
-

+++
++
++
+
++
+
-

+
+
+
+
+
+
+
+
+
+
+
+
+

a

+
+
+
+
+
+
+
+
+
+
+
+
+
+

++++++++
++++++++
+++++
+++++
++++++++
++++++++
++++++++
++++++
+++
+++

Ability to
stimulate
mucins
production
+
*a
*
*
*
*
*
*
*
*
*
*
*
*

The isolates were not examined for ability to stimulate mucins production in

normal colon cells. Lactobacillus rhamnosus isolates have the most positive
characteristics.
Conclusion
The results obtained in this study identified the bacterial composition in the stock
culture of ‘Amabere amaruranu’ cultured milk. The isolates included Lactobacillus
rhamnosus, Lactobacillus paracasei, Bacillus pumilus, Bacillus safensis, Acetobacter
sp, Staphylococcus aureus, Staphylococcus sciuri, and Staphylococcus epidermidis.
Lactobacillus rhamnosus isolates did not degrade mucin and showed antimicrobial
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effect against indicator strains. They were susceptible to eight antibiotics that are
commonly used in human clinical therapy. They were stable to bile but unstable to
acidic buffer at pH2. They showed some positive traits for consideration for probiotic
food production. Lactobacillus paracasei isolates were resistant to five antibiotics and
unstable to digestive tract conditions. Treatment of human CCD 841 CoN cells with
filter-sterilized Lactobacillus rhamnosus cell fractions demonstrated an increase in
MUC4 level by six-fold and MUC3 level by two-fold. Bacillus isolates demonstrated
stability to digestive tract conditions but demonstrate antibacterial activity. Bacillus
pumilus isolates were found to be resistant to all of the antibiotics tested. Acetobacter
and Staphylococcus isolates were unstable to invitro tests for stability to digestive tract
conditions. Staphylococcus sciuri was the only isolate that degraded mucin. Therefore,
Staphylococcus aureus, Staphylococcus sciuri, and Acetobacter isolates cannot be
considered suitable for probiotic. We concluded that Lactobacillus rhamnosus isolates
that did not degrade mucin and showed stability in acid and bile conditions,
demonstrated antimicrobial activity against indicator strains, were sensitive to
antibiotics, and showed capacity to stimulate increase in MUC4 and MUC3 levels in
human CCD 841 CoN cell model could be potential probiotic candidates.
Future Research
It is our hope to examine the antimicrobial activity of the Lactobacillus isolates in
details in order to determine the mechanism(s) by which they inhibited the growth of the
indicator strains. We are interested in studying the optimum concentration of the
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Lactobacillus rhamnosus extracts that gives the highest MUC4 and MUC3 levels in
normal colon cells.
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